Literature DB >> 21421456

Prognostic factors in desmoid tumours: an example of translational oncology.

Soledad Gallego Melcón.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21421456     DOI： 10.1007/s12094-011-0631-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  12 in total

1.  Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.

Authors:  Sébastien Salas; Frederic Chibon; Tetsuro Noguchi; Philippe Terrier; Dominique Ranchere-Vince; Pauline Lagarde; Jean Benard; Sébastien Forget; Camille Blanchard; Julien Dômont; Sylvie Bonvalot; Louis Guillou; Agnès Leroux; Agnes Mechine-Neuville; Patrick Schöffski; Marik Laë; Françoise Collin; Olivier Verola; Amelie Carbonnelle; Laure Vescovo; Binh Bui; Véronique Brouste; Hagay Sobol; Alain Aurias; Jean-Michel Coindre
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

2.  Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.

Authors:  Rashmi Chugh; J Kyle Wathen; Shreyaskumar R Patel; Robert G Maki; Paul A Meyers; Scott M Schuetze; Dennis A Priebat; Dafydd G Thomas; Jon A Jacobson; Brian L Samuels; Robert S Benjamin; Laurence H Baker
Journal:  Clin Cancer Res       Date:  2010-08-19       Impact factor: 12.531

3.  Multimodal treatment of desmoid tumours: the significance of local control.

Authors:  Bella Pajares; Esperanza Torres; Begoña Jiménez; Isabel Sevilla; Ana Rodríguez; José Manuel Rico; José Manuel Trigo; Emilio Alba
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

4.  Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.

Authors:  Colleen Wu; Saeid Amini-Nik; Saied Nik-Amini; Puviindran Nadesan; William L Stanford; Benjamin A Alman
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

5.  A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

Authors:  E Stoeckle; J M Coindre; M Longy; M Bui Nguyen Binh; G Kantor; M Kind; C Tunon de Lara; A Avril; F Bonichon; B Nguyen Bui
Journal:  Eur J Surg Oncol       Date:  2008-08-29       Impact factor: 4.424

6.  Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.

Authors:  Maria Fernanda C Amary; Patrick Pauwels; Els Meulemans; Guido M Roemen; Lily Islam; Bernadine Idowu; Konstantinos Bousdras; Timothy C Diss; Paul O'Donnell; Adrienne M Flanagan
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

7.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Authors:  Alexander J F Lazar; Daniel Tuvin; Shohrae Hajibashi; Sultan Habeeb; Svetlana Bolshakov; Empar Mayordomo-Aranda; Carla L Warneke; Dolores Lopez-Terrada; Raphael E Pollock; Dina Lev
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  Gene expression in aggressive fibromatosis.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  J Lab Clin Med       Date:  2004-02

Review 9.  Musculoskeletal desmoid tumors.

Authors:  Harish S Hosalkar; Jesse T Torbert; Edward J Fox; Thomas F Delaney; Albert J Aboulafia; Richard D Lackman
Journal:  J Am Acad Orthop Surg       Date:  2008-04       Impact factor: 3.020

10.  Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Authors:  Keith M Skubitz; Stefan Pambuccian; J Carlos Manivel; Amy P N Skubitz
Journal:  J Transl Med       Date:  2008-05-06       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.